| Estimated Vaccination Coverage^ with Individual Vaccines and Vaccination Series Among Children 19-35 Months of Age by Race/Ethnicity* -- US, National Immunization Survey, Q1/2007-Q4/2007† |
4+DTaP‡ | 3+Polio§ | 1+MMRll | 3+Hib¶ | 3+HepB** | 1+Var†† | 3+PCV‡‡ | 4+PCV§§ | 4:3:1llll | 4:3:1:3¶¶ | 4:3:1:3:3*** | 4:3:1:3:3:1††† | 4:3:1:3:3:1:3€ | 4:3:1:3:3:1:4€€ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| US National | 84.5±0.9 | 92.6±0.7 | 92.3±0.7 | 92.6±0.7 | 92.7±0.7 | 90.0±0.7 | 90.0±0.8 | 75.3±1.2 | 82.8±1.0 | 81.8±1.0 | 80.1±1.0 | 77.4±1.1 | 74.3±1.1 | 66.5±1.3 |
| White only, non-Hispanic | 85.3±1.2 | 92.6±0.9 | 92.1±0.8 | 92.9±0.9 | 92.5±0.9 | 89.2±1.0 | 89.8±0.9 | 76.6±1.4 | 83.3±1.2 | 82.6±1.2 | 81.0±1.3 | 77.5±1.3 | 74.1±1.4 | 67.0±1.6 |
| Black only, non-Hispanic | 82.3±2.7 | 91.1±2.1 | 91.5±2.0 | 90.8±2.2 | 91.2±2.1 | 89.8±2.2 | 89.5±2.2 | 70.3±3.4 | 81.0±2.8 | 79.5±2.9 | 77.5±3.1 | 75.3±3.2 | 72.9±3.3 | 62.0±3.6 |
| Hispanic | 83.8±2.2 | 93.0±1.6 | 92.6±1.6 | 93.5±1.4 | 93.6±1.6 | 90.6±1.7 | 91.0±1.7 | 75.4±2.6 | 82.4±2.2 | 81.5±2.3 | 79.8±2.4 | 78.0±2.5 | 75.1±2.6 | 67.0±2.8 |
| American Indian or Alaska Native only, non-Hispanic | 86.4±7.1 | 94.8±5.5 | 96.2±3.2 | 95.0±4.1 | 96.7±3.0 | 94.9±3.5 | 94.0±4.3 | 80.4±7.1 | 85.6±7.2 | 85.3±7.2 | 85.1±7.3 | 82.7±7.5 | 82.3±7.5 | 74.6±8.4 |
| Asian only, non-Hispanic | 87.5±4.0 | 95.0±2.6 | 93.9±3.5 | 91.0±3.4 | 93.8±2.9 | 93.7±2.9 | 86.8±4.7 | 75.0±5.9 | 85.5±4.6 | 81.9±5.1 | 80.7±5.2 | 79.4±5.3 | 75.1±6.1 | 68.6±6.5 |
| Native Hawaiian or Other Pacific Islander only, non-Hispanic | NA | 87.4±10.0 | 87.6±8.8 | NA | NA | 88.6±8.2 | NA | NA | NA | NA | NA | NA | NA | NA |
| Multiple Race, non-Hispanic | 84.2±5.1 | 92.3±4.5 | 94.6±2.0 | 90.1±4.9 | 92.1±4.5 | 91.6±2.7 | 89.4±4.7 | 74.1±5.6 | 82.4±5.2 | 80.9±5.4 | 78.7±5.5 | 75.5±5.6 | 73.4±5.7 | 66.2±5.9 |
| ^ Estimate=NA (Not Available) if the unweighted sample size for the denominator was <30 or (CI half width)/Estimate > 0.6 or (CI half width) >10. | ||||||||||||
| Estimates presented as point estimate (%) ± 95% Confidence Interval. | ||||||||||||
| * Self-reported by respondent. Individual racial groups do not include Hispanic children. Children of Hispanic ethnicity may be of any race. | ||||||||||||
| † Children in the Q1/2007-Q4/2007 National Immunization Survey were born between January 2004 and July 2006. | ||||||||||||
| ‡ 4 or more doses of any diphtheria and tetanus toxoids and pertussis vaccines including diphtheria and tetanus toxoids, and any acellular pertussis vaccine (DTaP/DTP/DT). | ||||||||||||
| § 3 or more doses of any poliovirus vaccine. | ||||||||||||
| ll 1 or more doses of measles-mumps-rubella vaccine. | ||||||||||||
| ¶ 3 or more doses of Haemophilus influenzae type b (Hib) vaccine. | ||||||||||||
| ** 3 or more doses of hepatitis B vaccine. | ||||||||||||
| †† 1 or more doses of varicella at or after child's first birthday, unadjusted for history of varicella illness. | ||||||||||||
| ‡‡ 3 or more doses of pneumococcal conjugate vaccine (PCV). | ||||||||||||
| §§ 4 or more doses of PCV. | ||||||||||||
| llll 4 or more doses of DTaP, 3 or more doses of poliovirus vaccine, and 1 or more doses of MMR. | ||||||||||||
| ¶¶ 4:3:1 plus 3 or more doses of Hib. | ||||||||||||
| *** 4:3:1:3 plus 3 or more doses of HepB. | ||||||||||||
| ††† 4:3:1:3:3 plus 1 or more doses of varicella vaccine. | ||||||||||||
| € 4:3:1:3:3 plus 1 or more doses of varicella vaccine and 3 or more doses of PCV. | ||||||||||||
| €€ 4:3:1:3:3 plus 1 or more doses of varicella vaccine and 4 or more doses of PCV. | ||||||||||||
| tab30_race_nat | ||||||||||